BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27227511)

  • 1. Synergistic Allosteric Mechanism of Fructose-1,6-bisphosphate and Serine for Pyruvate Kinase M2 via Dynamics Fluctuation Network Analysis.
    Yang J; Liu H; Liu X; Gu C; Luo R; Chen HF
    J Chem Inf Model; 2016 Jun; 56(6):1184-1192. PubMed ID: 27227511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native Mass Spectrometry Gives Insight into the Allosteric Binding Mechanism of M2 Pyruvate Kinase to Fructose-1,6-Bisphosphate.
    Gavriilidou AFM; Holding FP; Mayer D; Coyle JE; Veprintsev DB; Zenobi R
    Biochemistry; 2018 Mar; 57(11):1685-1689. PubMed ID: 29499117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation.
    Nandi S; Razzaghi M; Srivastava D; Dey M
    J Biol Chem; 2020 Dec; 295(51):17425-17440. PubMed ID: 33453989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.
    Dombrauckas JD; Santarsiero BD; Mesecar AD
    Biochemistry; 2005 Jul; 44(27):9417-29. PubMed ID: 15996096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate.
    Jurica MS; Mesecar A; Heath PJ; Shi W; Nowak T; Stoddard BL
    Structure; 1998 Feb; 6(2):195-210. PubMed ID: 9519410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular simulation of Tyr105 phosphorylated pyruvate kinase M2 to understand its structure and dynamics.
    Kalaiarasan P; Subbarao N; Bamezai RN
    J Mol Model; 2014 Sep; 20(9):2447. PubMed ID: 25208557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico-screening approaches for lead generation: identification of novel allosteric modulators of human-erythrocyte pyruvate kinase.
    Tripathi A; Safo MK
    Methods Mol Biol; 2012; 796():351-67. PubMed ID: 22052500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quaternary structure of pyruvate kinase type 1 from Escherichia coli at low nanomolar concentrations.
    Zhu T; Bailey MF; Angley LM; Cooper TF; Dobson RC
    Biochimie; 2010 Jan; 92(1):116-20. PubMed ID: 19800933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation.
    Macpherson JA; Theisen A; Masino L; Fets L; Driscoll PC; Encheva V; Snijders AP; Martin SR; Kleinjung J; Barran PE; Fraternali F; Anastasiou D
    Elife; 2019 Jul; 8():. PubMed ID: 31264961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and allosteric consequences of mutations in the subunit and domain interfaces and the allosteric site of yeast pyruvate kinase.
    Fenton AW; Blair JB
    Arch Biochem Biophys; 2002 Jan; 397(1):28-39. PubMed ID: 11747307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel allosteric regulators of human-erythrocyte pyruvate kinase.
    Kharalkar SS; Joshi GS; Musayev FN; Fornabaio M; Abraham DJ; Safo MK
    Chem Biodivers; 2007 Nov; 4(11):2603-17. PubMed ID: 18027374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant negative role of the glutamic acid residue conserved in the pyruvate kinase M(1) isozyme in the heterotropic allosteric effect involving fructose-1,6-bisphosphate.
    Ikeda Y; Taniguchi N; Noguchi T
    J Biol Chem; 2000 Mar; 275(13):9150-6. PubMed ID: 10734049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
    Pan Y; Wang W; Huang S; Ni W; Wei Z; Cao Y; Yu S; Jia Q; Wu Y; Chai C; Zheng Q; Zhang L; Wang A; Sun Z; Huang S; Wang S; Chen W; Lu Y
    J Cell Mol Med; 2019 Oct; 23(10):6846-6858. PubMed ID: 31343107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico screening, genotyping, molecular dynamics simulation and activity studies of SNPs in pyruvate kinase M2.
    Kalaiarasan P; Kumar B; Chopra R; Gupta V; Subbarao N; Bamezai RN
    PLoS One; 2015; 10(3):e0120469. PubMed ID: 25768091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The allosteric effect of fructose bisphosphate on muscle pyruvate kinase studied by infrared spectroscopy.
    Kumar S; Barth A
    J Phys Chem B; 2011 Oct; 115(39):11501-5. PubMed ID: 21870844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insight into mechanisms for dynamic regulation of PKM2.
    Wang P; Sun C; Zhu T; Xu Y
    Protein Cell; 2015 Apr; 6(4):275-287. PubMed ID: 25645022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of allosteric activation of yeast pyruvate kinase and identification of novel effectors using computational screening.
    Bond CJ; Jurica MS; Mesecar A; Stoddard BL
    Biochemistry; 2000 Dec; 39(50):15333-43. PubMed ID: 11112519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics Correlation Network for Allosteric Switching of PreQ1 Riboswitch.
    Wang W; Jiang C; Zhang J; Ye W; Luo R; Chen HF
    Sci Rep; 2016 Aug; 6():31005. PubMed ID: 27484311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-protein alanine-scanning mutagenesis of allostery: A large percentage of a protein can contribute to mechanism.
    Tang Q; Fenton AW
    Hum Mutat; 2017 Sep; 38(9):1132-1143. PubMed ID: 28407397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing the interactions in the fructose 1,6-bisphosphate binding site of human liver pyruvate kinase that contribute to allostery.
    Ishwar A; Tang Q; Fenton AW
    Biochemistry; 2015 Feb; 54(7):1516-24. PubMed ID: 25629396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.